Effects of ACE2 gene therapy on Diabetes

ACE2基因治疗对糖尿病的影响

基本信息

  • 批准号:
    7895432
  • 负责人:
  • 金额:
    $ 20.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Diabetes is a growing problem in all parts of the World. Clinical trials and animal models of type I and type II diabetes have shown that hyperactivity of angiotensin-II (Ang-II) signaling pathways contribute to the development of diabetes and diabetic complications. Of clinical relevance, blockade of the renin-angiotensin system (RAS) prevents new-onset diabetes and reduces the risk of diabetic complications. Angiotensin converting enzyme (ACE) 2 is a recently discovered mono- carboxypeptidase and the first homolog of ACE. It is thought to inhibit Ang-II signaling cascades mostly by cleaving Ang-II to generate Ang-(1-7), which effects oppose Ang-II and are mediated by the Mas receptor. The enzyme is present in various tissues and organs, including the kidney, liver, adipose tissue and pancreas. Its expression is elevated in the endocrine pancreas in diabetes and in the early phase during diabetic nephropathy. Pancreatic islets express both RAS components and NADPH oxidase (Nox) components, which are key elements in mediating oxidative stress. In the islet Ang-II and oxidative stress are both capable of decreasing insulin gene expression and secretion. ACE2 is hypothesized to oppose the ACE/Ang-II/AT1 receptor axis and may protect pancreatic beta- cell function by inhibiting both Nox activity and the Ang-II-mediated reduction of insulin gene expression and secretion. To manipulate ACE2 expression, we generated a novel adenovirus coding for ACE2 and reported increased ACE2 mRNA, protein and activity in cells and tissues. We hypothesize that ACE2 over-expression in the pancreas will reduce oxidative stress and ameliorate beta-cell function, thus leading to improved glucose homeostasis in diabetic mice. To test this hypothesis, we will address the following specific aims: 1) Determine the existence of a relationship between ACE2 expression and/or activity and diabetes; 2) Evaluate the consequences of ACE2 over-expression in diabetic mice; 3) Establish whether ACE2 over-expression improves pancreatic beta-cell function in diabetes. To achieve these goals, we will first use ACE2 knockout and db/db mouse (type 2 diabetes) models to establish the relationship between ACE2 and diabetes. Then we will combine state of the art molecular, pharmacological and physiological tools for in vitro (isolated islets) and in vivo (pancreas) gene therapy in pre-diabetic and young diabetic db/db mice. Finally, we will address the mechanisms by which ACE2 could potentially counterbalance the deleterious effects of the hyperactive RAS in diabetes. This proposal will show evidence of the beneficial effects of ACE2 over-expression on the normalization of blood glucose and highlight ACE2 as a new target for the treatment of diabetes. PUBLIC HEALTH RELEVANCE: Approximately 8% of Americans are affected by diabetes, a well known risk factor for cardiovascular diseases, and it is expected to grow due to the current obesity epidemic in the Western World. Using gene therapy in a mouse model of type 2 diabetes, this application will describe the ability of a new enzyme, ACE2, to regulate blood glucose levels. If confirmed, ACE2 could become a new target for the treatment of type 2 diabetes.
描述(由申请人提供):糖尿病在世界各地都是一个日益严重的问题。I型和II型糖尿病的临床试验和动物模型表明,血管紧张素-II (Ang-II)信号通路的过度活跃有助于糖尿病和糖尿病并发症的发展。具有临床意义的是,阻断肾素-血管紧张素系统(RAS)可预防新发糖尿病并降低糖尿病并发症的风险。血管紧张素转换酶(ACE) 2是最近发现的一种单羧基肽酶,也是ACE的第一个同源物。它被认为主要通过切割Ang- ii产生Ang-(1-7)来抑制Ang- ii信号级联反应,而Ang-(1-7)的作用是对抗Ang- ii的,并由Mas受体介导。这种酶存在于各种组织和器官中,包括肾脏、肝脏、脂肪组织和胰腺。它的表达在糖尿病的内分泌胰腺和糖尿病肾病的早期阶段升高。胰岛同时表达RAS成分和NADPH氧化酶(Nox)成分,它们是介导氧化应激的关键因素。在胰岛中,Ang-II和氧化应激都能降低胰岛素基因的表达和分泌。ACE2被推测与ACE/Ang-II/AT1受体轴相反,并可能通过抑制Nox活性和Ang-II介导的胰岛素基因表达和分泌的减少来保护胰腺β细胞功能。为了操纵ACE2的表达,我们产生了一种新的编码ACE2的腺病毒,并报道了细胞和组织中ACE2 mRNA、蛋白和活性的增加。我们假设ACE2在胰腺中的过度表达会减少氧化应激并改善β细胞功能,从而改善糖尿病小鼠的葡萄糖稳态。为了验证这一假设,我们将解决以下具体目标:1)确定ACE2表达和/或活性与糖尿病之间存在的关系;2)评价ACE2过表达对糖尿病小鼠的影响;3)确定ACE2过表达是否改善糖尿病胰腺β细胞功能。为了实现这些目标,我们将首先使用ACE2敲除和db/db小鼠(2型糖尿病)模型来建立ACE2与糖尿病之间的关系。然后,我们将结合最先进的分子,药理学和生理学工具,体外(分离胰岛)和体内(胰腺)基因治疗糖尿病前期和年轻糖尿病db/db小鼠。最后,我们将阐述ACE2可能潜在地抵消糖尿病中过度活跃的RAS的有害影响的机制。这一提议将证明ACE2过表达对血糖正常化的有益作用,并突出ACE2作为治疗糖尿病的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC D LAZARTIGUES其他文献

ERIC D LAZARTIGUES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC D LAZARTIGUES', 18)}}的其他基金

Targeting ADAM17 maturation in resistant hypertension.
靶向顽固性高血压中 ADAM17 的成熟。
  • 批准号:
    10608153
  • 财政年份:
    2022
  • 资助金额:
    $ 20.21万
  • 项目类别:
Targeting ADAM17 maturation in resistant hypertension.
靶向顽固性高血压中 ADAM17 的成熟。
  • 批准号:
    10432585
  • 财政年份:
    2022
  • 资助金额:
    $ 20.21万
  • 项目类别:
SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis
SARS-CoV-2 在大脑中的趋向性及其与 COVID-19 发病机制的关系
  • 批准号:
    10272724
  • 财政年份:
    2021
  • 资助金额:
    $ 20.21万
  • 项目类别:
COVID19: SARS-CoV-2 and ACE2 interaction in hypertension
COVID19:SARS-CoV-2 和 ACE2 在高血压中的相互作用
  • 批准号:
    10152313
  • 财政年份:
    2021
  • 资助金额:
    $ 20.21万
  • 项目类别:
COVID19: SARS-CoV-2 and ACE2 interaction in hypertension
COVID19:SARS-CoV-2 和 ACE2 在高血压中的相互作用
  • 批准号:
    10398819
  • 财政年份:
    2021
  • 资助金额:
    $ 20.21万
  • 项目类别:
Targeting ACE2 ubiquitination for hypertension
靶向 ACE2 泛素化治疗高血压
  • 批准号:
    10318183
  • 财政年份:
    2019
  • 资助金额:
    $ 20.21万
  • 项目类别:
Targeting ACE2 ubiquitination for hypertension
靶向 ACE2 泛素化治疗高血压
  • 批准号:
    10534148
  • 财政年份:
    2019
  • 资助金额:
    $ 20.21万
  • 项目类别:
New strategies to restore ACE2 compensatory activity in neurogenic hypertension
恢复神经源性高血压中 ACE2 代偿活性的新策略
  • 批准号:
    10266017
  • 财政年份:
    2018
  • 资助金额:
    $ 20.21万
  • 项目类别:
Effects of ACE2 gene therapy on Diabetes
ACE2基因治疗对糖尿病的影响
  • 批准号:
    8102099
  • 财政年份:
    2010
  • 资助金额:
    $ 20.21万
  • 项目类别:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
P7:针对大脑的 ACE2 过度表达和血压调节
  • 批准号:
    7959748
  • 财政年份:
    2009
  • 资助金额:
    $ 20.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了